Awards & Advancement

Marken appoints two independent directors to board

Tuesday, March 5, 2013 04:10 PM

Marken, based in Research Triangle Park, N.C., has appointed two independent directors to its board, as a result of Marken's recent restructuring completed Dec. 21, 2012.  They are Timothy C. Tyson and Michael O'Donnell.

More... »

Trovagene appoints Erlander chief scientific officer

Monday, March 4, 2013 02:15 PM

San Diego-based Trovagene, a developer of transrenal molecular diagnostics, has named Mark Erlander, Ph.D., chief scientific officer.  Erlander has more than 18 years of experience directing research teams with a strong focus in oncology-based molecular diagnostics. 

More... »

Clinical Network Services appoints Francis to BioDesk

Monday, March 4, 2013 02:13 PM

Clinical Network Services (CNS), an Australian-based CRO offering integrated development services in phase I and II trials, has appointed ex-Therapeutic Goods Administration (TGA) toxicologist Dr. Douglas Francis senior regulatory toxicologist for the company’s BioDesk product development planning and regulatory affairs service.

More... »

INC Research promotes Tierney to executive vice president, Asia/Pacific

Friday, March 1, 2013 02:47 PM

Therapeutically focused CRO INC Research has promoted Garth Tierney to executive vice president, Asia/Pacific, responsible for driving the strategic development and overall growth of Asia/Pacific clinical research operations. Tierney, who was INC Research’s regional general manager for Australia and Southeast Asia, co-founded Trident Clinical Research, an Australia-based CRO acquired by INC Research in 2011 after 14 years of operation.

More... »

Accelovance names Boccia oncology medical director

Friday, March 1, 2013 02:45 PM

Accelovance has named Dr. Ralph Boccia, M.D., FACP, oncology medical director.  The Rockville, Md.-based CRO caters to biotech and small/mid-sized pharma sponsors.

More... »

DelMar Pharmaceuticals names Bell to board of directors

Thursday, February 28, 2013 02:34 PM

Vancouver-based DelMar Pharmaceuticals has appointed John K. Bell to the company's board of directors.

More... »

Creabilis names Moukheibir to board of directors

Thursday, February 28, 2013 02:33 PM

Creabilis, a late clinical stage European biotechnology company specializing in developing treatments in dermatology, inflammation and pain, has appointed Catherine Moukheibir to its board of directors.

More... »

De Silva named president and CEO of Endo Health Solutions

Wednesday, February 27, 2013 11:25 AM

Endo Health Solutions, a Malvern, Penn.-based diversified healthcare company, has named Rajiv De Silva as president and CEO, effective March 18. De Silva, who will also join the Endo board of directors, succeeds David Holveck, who is retiring.

More... »

C-Path names Martha Brumfield as CEO

Tuesday, February 26, 2013 11:58 AM

The board of directors of the Critical Path Institute (C-Path), an independent, nonprofit organization, have named Martha Brumfield, Ph.D., as interim president and CEO. Brumfield, C-Path’s former director of international and regulatory programs, will take over immediately for Carolyn Compton, M.D., Ph.D. who will be assuming a new position at Arizona State University (ASU).

More... »

BMS appoints Judge as senior vice president, human resources

Thursday, February 21, 2013 08:00 AM

Global biopharmaceutical company Bristol-Myers Squibb (BMS) has appointed Ann Powell Judge as senior vice president, Human Resources.

More... »